Trial Evidence Supporting Early AOM Use Recent clinical trials demonstrate the effectiveness of early anti-obesity medication (AOM) intervention for patients showing minimal response to behavioral therapy (BT) alone
Results Timeline: Expected results are seen in approximately 4 weeks following the treatment
We must also consider that pediatric dosage forms may be more expensive than adult formulations [23], there is a potential for lifelong reliance on these medications if started in childhood, and GLP-1RA may require lifestyle interventions [Reference Sandsdal, Juhl, Jensen, Lundgren, Janus and Blond24] to optimize safety, efficacy, and value during growth and development
Dosing protocols, injection sites, timelines, and what Canadians can realistically expect
Archived from the original on 17 May 2019
Oxidative stress and cardiovascular risk in type 1 diabetes mellitus: insights from the DCCT/EDIC study